{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:46Z","timestamp":1793707966894,"version":"4.6.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["1021472"],"award-info":[{"award-number":["1021472"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"Universidad Nacional Autonoma de Mexico Direccion General de Asuntos del Personal Academico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.arcmed.2023.102916","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T02:53:21Z","timestamp":1701399201000},"page":"102916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clavulanic Acid and its Potential Therapeutic Effects on the Central Nervous System"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-9717","authenticated-orcid":false,"given":"Luis Gerardo","family":"Balcazar-Ochoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-2886","authenticated-orcid":false,"given":"Rosa","family":"Ventura-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe Esther","family":"\u00c1ngeles-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-9651","authenticated-orcid":false,"given":"Claudia","family":"G\u00f3mez-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-5069","authenticated-orcid":false,"given":"Omar Francisco","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-1105","authenticated-orcid":false,"given":"Ra\u00fal","family":"Sampieri-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-0461","authenticated-orcid":false,"given":"Anah\u00ed","family":"Chavarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-1419","authenticated-orcid":false,"given":"Abimael","family":"Gonz\u00e1lez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102916_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2023.102916_bib0002","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnins.2019.00236","article-title":"Repurposing of the \u03b2-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review","volume":"13","author":"Yimer","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0003","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/00498258609038967","article-title":"The disposition of clavulanic acid in man","volume":"16","author":"Bolton","year":"1986","journal-title":"Xenobiotica"},{"key":"10.1016\/j.arcmed.2023.102916_bib0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biotechadv.2008.03.002","article-title":"Clavulanic acid: a review","volume":"26","author":"Saudagar","year":"2008","journal-title":"Biotechnol adv"},{"key":"10.1016\/j.arcmed.2023.102916_bib0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/antibiotics10080995","article-title":"Old and new beta-lactamase inhibitors: Molecular structure, mechanism of action, and clinical Use","volume":"10","author":"Carcione","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.arcmed.2023.102916_bib0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ddr.20378","article-title":"Clavulanic acid protects neurons in pharmacological models of neurodegenerative diseases","volume":"71","author":"Huh","year":"2010","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pbb.2009.04.013","article-title":"Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects","volume":"93","author":"Kim","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.arcmed.2023.102916_bib0008","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/fcp.12729","article-title":"Treatment with the combination of clavulanic acid and valproic acid led to recovery of neuronal and behavioral deficits in an epilepsy rat model","volume":"35","author":"Liu","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0009","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11064-021-03308-y","article-title":"Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats","volume":"46","author":"Kolahdouz","year":"2021","journal-title":"Neurochem Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0010","first-page":"3312","article-title":"Clavulanic acid exhibits anti-inflammatory effects on carrageenan-induced paw edema model of inflammation in rats","volume":"3","author":"Banani","year":"2012","journal-title":"Ann Biol Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0011","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/JPR.S154661","article-title":"Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model","author":"Ochoa-Aguilar","year":"2018","journal-title":"J Pain Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ddr.21381","article-title":"Antiallodynic Activity of Ceftriaxone and Clavulanic Acid in Acute Administration is Associated with Serum TNF-\u03b1 Modulation and Activation of Dopaminergic and Opioidergic Systems","volume":"78","author":"Ochoa-Aguilar","year":"2017","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0013","first-page":"315","article-title":"Antinociceptive effect of clavulanic acid and its preventive activity against development of morphine tolerance and dependence in animal models","volume":"9","author":"Hajhashemi","year":"2014","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109306","article-title":"The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens","volume":"232","author":"Philogene-Khalid","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.arcmed.2023.102916_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2014.05.012","article-title":"Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?","volume":"142","author":"Schroeder","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.arcmed.2023.102916_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainres.2015.07.008","article-title":"Amoxicillin and amoxicillin\/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions","volume":"1622","author":"Goodwani","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0017","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/0976-500X.142439","article-title":"Evaluation of potassium clavulanate on ethanol consumption and decision making in the model of ethanol dependence in mice","volume":"5","author":"Jadhav","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","article-title":"Beta-lactam antibiotics: from antibiosis to resistance and bacteriology","volume":"118","author":"Kong","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.arcmed.2023.102916_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871523015666160517114027","article-title":"Review of Antibiotic and Non-Antibiotic Properties of Beta-lactam Molecules","volume":"15","author":"Ochoa-Aguilar","year":"2016","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1016\/j.arcmed.2023.102916_bib0020","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-Lactamases and \u03b2-Lactamase Inhibitors in the 21st Century","volume":"431","author":"Tooke","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0021","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7164\/antibiotics.29.668","article-title":"Naturally-occurring beta-lactamase inhibitors with antibacterial activity","volume":"29","author":"Brown","year":"1976","journal-title":"J Antibiot (Tokyo)"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2023.102916_bib0022","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkh050","article-title":"Augmentin (amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent","volume":"53","author":"White","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0023","series-title":"Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions","author":"Aronson","year":"2016"},{"key":"10.1016\/j.arcmed.2023.102916_bib0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eimc.2008.12.001","article-title":"Antibi\u00f3ticos betalact\u00e1micos","volume":"27","author":"Su\u00e1rez","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.arcmed.2023.102916_bib0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1039\/np9971400309","article-title":"Chemistry and biosynthesis of clavulanic acid and other clavams","volume":"14","author":"Baggaley","year":"1997","journal-title":"Natural Prod Rep"},{"key":"10.1016\/j.arcmed.2023.102916_bib0026","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1248\/cpb.29.3334","article-title":"Stability of clavulanic acid in aqueous solutions","volume":"29","author":"Haginaka","year":"1981","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.arcmed.2023.102916_bib0027","doi-asserted-by":"crossref","first-page":"e01707","DOI":"10.1128\/AAC.01707-20","article-title":"Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to \u03b2-Lactam Antibiotics","volume":"65","author":"Fang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0028","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/030006058901700606","article-title":"Oral bioavailability of ampicillin and amoxycillin alone and bound in fixed proportions to sulbactam and clavulanic acid","volume":"17","author":"Desager","year":"1989","journal-title":"J Int Med Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0029","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.29.4.614","article-title":"Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin","volume":"29","author":"Horber","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2011.09.032","article-title":"Clavulanic acid increases dopamine release in neuronal cells through a mechanism involving enhanced vesicle trafficking","volume":"504","author":"Kost","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2023.102916_bib0031","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(80)91118-6","article-title":"Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study","volume":"1","author":"Ball","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102916_bib0032","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.22.3.353","article-title":"Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination","volume":"22","author":"Adam","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0033","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00003495-198122050-00001","article-title":"Amoxycillin\/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use","volume":"22","author":"Brogden","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.arcmed.2023.102916_bib0034","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","article-title":"Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases","volume":"33","author":"Larrey","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2023.102916_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112664","article-title":"Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways","volume":"158","author":"Petrov","year":"2021","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0036","first-page":"139","article-title":"Amoxicillin-clavulanic acid therapy may be associated with severe side effects-review of the literature","volume":"6","author":"Gresser","year":"2001","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9343(98)00362-3","article-title":"Adverse effects of outpatient parenteral antibiotic therapy","volume":"106","author":"Hoffman-Terry","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.arcmed.2023.102916_bib0038","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00018-015-1937-8","article-title":"Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease","volume":"72","author":"Takahashi","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0039","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2023.102916_bib0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00726-015-2117-8","article-title":"Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice","volume":"48","author":"Kim","year":"2016","journal-title":"Amino acids"},{"key":"10.1016\/j.arcmed.2023.102916_bib0041","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0006-3223(98)00300-X","article-title":"Brain circuits in panic disorder","volume":"44","author":"Coplan","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.arcmed.2023.102916_bib0042","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2009.03.009","article-title":"Clavulanic acid stimulates sexual behaviour in male rats","volume":"609","author":"Chan","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0043","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.pbb.2012.12.001","article-title":"Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine","volume":"103","author":"Sanna","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.arcmed.2023.102916_bib0044","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijir.3900719","article-title":"Dopamine and sexual function","volume":"13","author":"Giuliano","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neubiorev.2010.10.014","article-title":"Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats","volume":"35","author":"Melis","year":"2011","journal-title":"Neurosc Biobehav Rev"},{"key":"10.1016\/j.arcmed.2023.102916_bib0046","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/bne0000297","article-title":"The effects of clavulanic acid and amoxicillin on cue-primed reinstatement of cocaine seeking","volume":"133","author":"Bechard","year":"2019","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0047","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102916_bib0048","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03036449","article-title":"Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview","volume":"7","author":"Jackson-Lewis","year":"2005","journal-title":"Neurotox Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0049","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson's disease genetics and pathophysiology","volume":"44","author":"V\u00e1zquez-V\u00e9lez","year":"2021","journal-title":"Ann Rev Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0050","first-page":"2","article-title":"The role of caspases in Parkinson's Disease pathogenesis: a brief look at the mitochondrial pathway. Austin Alzheimer's and Parkinson's","volume":"1","author":"Chaudhry","year":"2014","journal-title":"Dis"},{"key":"10.1016\/j.arcmed.2023.102916_bib0051","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2012.06.005","article-title":"Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells","volume":"1469","author":"Kost","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0052","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2443.1998.00223.x","article-title":"Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?","volume":"3","author":"Tsujimoto","year":"1998","journal-title":"Genes Cells"},{"key":"10.1016\/j.arcmed.2023.102916_bib0053","first-page":"123","article-title":"Increased Bax\/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis","volume":"21","author":"Salakou","year":"2007","journal-title":"In vivo"},{"key":"10.1016\/j.arcmed.2023.102916_bib0054","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/35052055","article-title":"Rab proteins as membrane organizers","volume":"2","author":"Zerial","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/membranes4040642","article-title":"The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors","volume":"4","author":"Bucci","year":"2014","journal-title":"Membranes"},{"key":"10.1016\/j.arcmed.2023.102916_bib0056","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/01480545.2018.1468772","article-title":"Neuroprotective effect of clavulanic acid on trimethyltin (TMT)-induced cytotoxicity in PC12 cells","volume":"42","author":"Silakhori","year":"2019","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0057","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41583-019-0126-4","article-title":"Neuron\u2013glia interactions in the pathophysiology of epilepsy","volume":"20","author":"Patel","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00023210-200115010-00004","article-title":"Glutamate receptors and nociception: implications for the drug treatment of pain","volume":"15","author":"Fundytus","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arcmed.2023.102916_bib0059","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.neuroscience.2010.06.041","article-title":"\u03b2-lactamase inhibitors display antiseizure properties in an invertebrate assay","volume":"169","author":"Rawls","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2023.102916_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ejp.1117","article-title":"The \u03b2-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain","volume":"22","author":"Kristensen","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.arcmed.2023.102916_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-011-0662-1","article-title":"Clavulanic acid does not affect convulsions in acute seizure tests in mice","volume":"119","author":"Gasior","year":"2012","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.arcmed.2023.102916_bib0062","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0091-3057(01)00468-3","article-title":"Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures","volume":"68","author":"Kami\u0144ski","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.arcmed.2023.102916_bib0063","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.seizure.2014.11.006","article-title":"Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans?","volume":"24","author":"Yuen","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.arcmed.2023.102916_bib0064","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1528-1157.1969.tb03838.x","article-title":"Laboratory evaluation of antiepileptic drugs. Review of laboratory methods","volume":"10","author":"Swinyard","year":"1969","journal-title":"Epilepsia"},{"key":"10.1016\/j.arcmed.2023.102916_bib0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2017.08.013","article-title":"\u03b2-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats","volume":"657","author":"Hakami","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2023.102916_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-018-1194-z","article-title":"Effects of Clavulanic Acid Treatment on Reinstatement to Methamphetamine, Glial Glutamate Transporters, and mGluR 2\/3 Expression in P Rats Exposed to Ethanol","volume":"67","author":"Althobaiti","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0067","doi-asserted-by":"crossref","first-page":"345","DOI":"10.32598\/bcn.10.4.799.2","article-title":"Upregulation of glutamate transporter 1 by clavulanic acid administration and attenuation of allodynia and hyperalgesia in neuropathic rats","volume":"10","author":"Amin","year":"2019","journal-title":"Basic Clin Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0068","doi-asserted-by":"crossref","first-page":"465","DOI":"10.31887\/DCNS.2013.15.4\/sarlt","article-title":"Non-Alzheimer's disease-related memory impairment and dementia","volume":"15","author":"Arlt","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0069","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1021\/acsomega.2c00231","article-title":"Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer's Disease","volume":"7","author":"Anoush","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.arcmed.2023.102916_bib0070","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ddr.21595","article-title":"Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats","volume":"80","author":"Ghanbarabadi","year":"2019","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0071","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1474-4422(11)70066-7","article-title":"Stroke and the immune system: from pathophysiology to new therapeutic strategies","volume":"10","author":"Macrez","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0072","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2015.05.041","article-title":"Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments","volume":"87","author":"George","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.arcmed.2023.102916_bib0073","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0074","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications","volume":"18","author":"Arranz","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-1047(86)90750-8","article-title":"Scopolamine effects on memory retention in mice: a model of dementia?","volume":"45","author":"Flood","year":"1986","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0076","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.biopha.2018.10.019","article-title":"Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation","volume":"108","author":"Mohan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2023.102916_bib0077","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1471-4159.2009.06347.x","article-title":"Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro","volume":"111","author":"Lewerenz","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2023.102916_bib0078","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41398-021-01261-6","article-title":"Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents","volume":"11","author":"Yao","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.arcmed.2023.102916_bib0079","first-page":"87","article-title":"Burden of Mental, Neurological, Substance Use Disorders and Self-Harm in North America: A Comparative Epidemiology of Canada, Mexico, and the United States","volume":"65","author":"Vigo","year":"2020","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.arcmed.2023.102916_bib0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00702-018-1957-2","article-title":"Dopamine and addiction: what have we learned from 40 years of research","volume":"126","author":"Solinas","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.arcmed.2023.102916_bib0081","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0082","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10571-021-01105-3","article-title":"The Role of Glia in Addiction: Dopamine as a Modulator of Glial Responses in Addiction","volume":"42","author":"Jim\u00e9nez-Gonz\u00e1lez","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.arcmed.2023.102916_bib0083","first-page":"730","article-title":"Clavulanic acid improves ethanol withdrawal symptoms in rats","volume":"23","author":"Mohebbi","year":"2020","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0084","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/j.pain.0000000000001306","article-title":"Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states","volume":"159","author":"Bruno","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.arcmed.2023.102916_bib0085","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced proinflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0086","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2015.12.006","article-title":"Involvement of TLR4 in the long-term epigenetic changes, rewarding and anxiety effects induced by intermittent ethanol treatment in adolescence","volume":"53","author":"Montesinos","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.arcmed.2023.102916_bib0087","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1543809","article-title":"Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage","volume":"2016","author":"Hern\u00e1ndez","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.arcmed.2023.102916_bib0088","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ait.2020.94756","article-title":"The opioid crisis in North America: facts and future lessons for Europe","volume":"52","author":"Ayoo","year":"2020","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.arcmed.2023.102916_bib0089","doi-asserted-by":"crossref","first-page":"289","DOI":"10.32598\/bcn.9.4.289","article-title":"Effects of clavulanic acid on the acquisition and reinstatement following morphine-induced conditioned place preference in mice","volume":"9","author":"Mehri","year":"2018","journal-title":"Basic Clin Neurosci"},{"key":"10.1016\/j.arcmed.2023.102916_bib0090","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised IASP definition of pain: Concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.arcmed.2023.102916_bib0091","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.arcmed.2023.102916_bib0092","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.arcmed.2023.102916_bib0093","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.arcmed.2023.102916_bib0094","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1172\/JCI45178","article-title":"What is this thing called pain?","volume":"120","author":"Woolf","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2023.102916_bib0095","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1172\/JCI43766","article-title":"Central modulation of pain","volume":"120","author":"Ossipov","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2023.102916_bib0096","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(99)02396-3","article-title":"The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum","volume":"855","author":"Magnusson","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2023.102916_bib0097","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1744-8069-6-75","article-title":"Inflammatory nociception diminishes dopamine release and increases dopamine D2 receptor mRNA in the rat's insular cortex","volume":"6","author":"Coffeen","year":"2010","journal-title":"Mol Pain"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:52:46Z","timestamp":1759261966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0188440923001546"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102916","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clavulanic Acid and its Potential Therapeutic Effects on the Central Nervous System","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102916"}}